|
Market Closed -
Nasdaq
23:00:00 31/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 7.93B 7.52B 6.79B 12.79B 864B 12.96B 89.94B 34.61B 442B 33.83B 33.1B 1,416B | P/E 2024 |
-13.8x | P/E 2025 | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 8.03B 7.07B 6.7B 6.05B 11.4B 770B 11.55B 80.17B 30.85B 394B 30.16B 29.5B 1,262B | EV / Sales 2024 |
3,310x | EV / Sales 2025 | 447x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
CBOE
| CRNX | Real-time | |
|
Deutsche Boerse AG
| 6Z4 | Delayed | |
|
Börse Stuttgart
| 6Z4 | Delayed |
Last Transcript: Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 3 months | +127.02% | ||
| 6 months | +133.89% | ||
| Current year | +82.49% |
| Current year | 32.3 |  | 85.01 |
| 1 year | 32.3 | | 85.01 |
| 3 years | 24.1 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 01/09/2026 |
Omar White
SEC | Corporate Secretary | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 01/09/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 A | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 9/1/26 A | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 9/1/26 A | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.04M 915K 867K 783K 1.48M 99.62M 1.49M 10.37M 3.99M 50.93M 3.9M 3.82M 163M | 7.7M 6.78M 6.42M 5.8M 10.93M 738M 11.07M 76.82M 29.56M 377M 28.9M 28.27M 1.21B |
| Net income | -298M -263M -249M -225M -424M -28.61B -429M -2.98B -1.15B -14.63B -1.12B -1.1B -46.9B | -465M -410M -388M -350M -661M -44.62B -669M -4.64B -1.79B -22.81B -1.75B -1.71B -73.13B |
| Net Debt | -1.3B -1.15B -1.09B -981M -1.85B -125B -1.87B -13B -5B -63.84B -4.89B -4.78B -205B | -979M -862M -817M -738M -1.39B -93.9B -1.41B -9.78B -3.76B -48B -3.68B -3.6B -154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
